PPC
AVNS

Park Place Capital’s Avanos Medical AVNS Stock Holding History

Park Place Capital’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-471
Closed -$9.52K – 869
2023
Q3 		$9.52K Hold
471
– – ﹤0.01% 764
2023
Q2 		$12K Hold
471
– – ﹤0.01% 742
2023
Q1 		$14K Buy
471
+15
+3% +$435 ﹤0.01% 705
2022
Q4 		$12K Buy
+456
New +$11.2K ﹤0.01% 732

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Park Place Capital's AVNS Position: Q4 2023 in Review

Park Place Capital sold out of Avanos Medical (AVNS) in Q4 2023, closing a stake of 471 shares — an estimated $9.52K sold.

Park Place Capital first reported a position in AVNS in Q4 2022 and held it in 4 quarters. The position peaked at $14K in Q1 2023. 265 funds tracked by Wall St. Rank hold AVNS as of Q4 2023.

  • Park Place Capital reported no remaining Avanos Medical position as of Q4 2023 after selling out during the quarter.
  • Park Place Capital sold 471 Avanos Medical shares in Q4 2023, an estimated $9.52K.
  • Park Place Capital first reported a position in Avanos Medical in Q4 2022 and held it in 4 quarters.
  • Park Place Capital's Avanos Medical position peaked at $14K in Q1 2023.
  • 265 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2023.

Based on Park Place Capital's 13F filing for Q4 2023, filed 24 Jan 2024.